What is the prognosis for stage 4 glioblastoma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Stage 4 Glioblastoma Prognosis
Glioblastoma (GBM) is classified as a Grade IV brain tumor by the World Health Organization, representing the most aggressive form of brain cancer. Here's what the medical evidence tells us:
Survival Statistics
According to the National Cancer Institute (NCI) and American Cancer Society:
- The median survival time for glioblastoma is approximately 12-18 months with standard treatment
- The 5-year relative survival rate is approximately 6-7%
- However, these are statistical averages, and individual outcomes vary significantly
Factors That Influence Prognosis
The NCCN (National Comprehensive Cancer Network) Guidelines identify several factors that can affect outcomes:
Favorable factors:
- Younger age (under 50-60)
- Good performance status (ability to carry out daily activities)
- MGMT promoter methylation (a genetic marker that predicts better response to chemotherapy)
- Extent of surgical resection (how much tumor can be safely removed)
- IDH mutation status (though rare in primary GBM)
Less favorable factors:
- Older age
- Poor functional status
- Tumor location that limits surgical options
- Unmethylated MGMT status
Standard Treatment Approach
According to ASCO (American Society of Clinical Oncology) guidelines, the standard treatment typically includes:
- Maximal safe surgical resection when possible
- Concurrent radiation and temozolomide chemotherapy (the Stupp protocol)
- Adjuvant temozolomide for 6-12 months
This combined approach has been shown to extend survival compared to radiation alone.
Important Context
Individual variation matters greatly. Some patients live significantly longer than the median, while others have shorter survival times. Factors like:
- Your specific tumor biology
- Response to treatment
- Overall health
- Access to clinical trials
- Newer treatment options (tumor treating fields/Optune, immunotherapy trials)
...all play important roles that statistics alone cannot capture.
Moving Forward
I strongly encourage you to:
- Have an in-depth discussion with your neuro-oncologist about your specific situation
- Ask about clinical trials that might be appropriate for you
- Consider getting a second opinion at a comprehensive cancer center
- Discuss quality of life goals alongside treatment options
The American Cancer Society emphasizes that while GBM is a serious diagnosis, treatment advances continue to emerge, and supportive care has improved significantly to help maintain quality of life during treatment.
Is there a specific aspect of prognosis or treatment you'd like to discuss further?
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Brain Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Brain Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: